Products that do not conform to specifications are not adequately controlled.
Inspection Record
Aeon Biotherapeutics Corp. — FDA 483 Findings
Inspectors Creighton T Tuzon · Nisha C PatelThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Procedures to prevent contamination of equipment or product by substances that may have an adverse effect on product quality have not been adequately established.
Procedures foM of nonconforming product have not been adequately established.
Procedures for corrective and preventive action have not been adequately established.
A record as of the US FDA document published on 2026-10-21. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.